STELARA^® in Inflammatory Bowel Disease

Take a look at some of our activities at ECCO 2020, including videos from experts and key speakers on STELARA^® in UC and CD.

Introducing the STARDUST trial – A unique study exploring the clinical value of STELARA^®, and the first to investigate intestinal ultrasound (IUS) for monitoring of CD in an international, multicentre clinical trial.^[4][5][6]

Find out more in the videos below

STELARA^® - Now approved in UC

ECCO was the perfect setting to discuss some of the unmet needs in UC and what’s important in the treatment of this disease.

Find out more in the videos below

New updates to ECCO guidelines: STELARA^® is now strongly recommended for induction and maintenance of remission in patients with CD. In these two videos Prof. Alessandro Armuzzi provides a description of the updates and his interpretations.